TEVA: Koefisien bali modal nimbang wutah Teva Pharmaceuticals

Steady growth in branded drug sales has provided Teva Pharmaceutical Industries (TEVA) with high liquidity. The GURU.Markets service features a PEG ratio chart, where the latest value is recorded as 2.22. While quotes depend on fierce pricing competition in the generics segment, competent management is successfully reducing debt and introducing new biosimilars, effectively managing anti-crisis processes.
Rincian analitis perusahaan Teva Pharmaceutical Industries Limited (TEVA)

The PEG ratio determines investment attractiveness by comparing a company's market value to its net income growth rate, where a value below one indicates an undervalued asset. By analyzing historical PEG levels, an investor can gauge the scaling efficiency of Teva Pharmaceutical Industries (TEVA), whose dominance in the generics segment and control over active pharmaceutical ingredient production ensure low costs and sustainable profit growth.